| 1 |
30930179 | Repeated treatments with the D1 dopamine receptor agonist SKF-38393 modulate cell viability via sustained ERK-Bad-Bax activation in dopaminergic neuronal cells. | 2019 Jul 23 |
4 |
| 2 |
29232769 | Anti-Parkinsonian and anti-dyskinetic profiles of two novel potent and selective nociceptin/orphanin FQ receptor agonists. | 2018 Mar |
1 |
| 3 |
23152595 | Nociceptin/orphanin FQ receptor agonists attenuate L-DOPA-induced dyskinesias. | 2012 Nov 14 |
1 |
| 4 |
15229233 | Sustained extracellular signal-regulated kinase 1/2 phosphorylation in neonate 6-hydroxydopamine-lesioned rats after repeated D1-dopamine receptor agonist administration: implications for NMDA receptor involvement. | 2004 Jun 30 |
2 |